相似文献
1
Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus.
Br J Cancer. 1980 Apr;41(4):609-17. doi: 10.1038/bjc.1980.104.
2
Corynebacterium parvum: antibodies measured with the enzyme-linked immunosorbent assay (ELISA) in normal human sera and sera from cancer patients undergoing treatment.
Ann Immunol (Paris). 1982 Nov-Dec;133D(3):305-11.
3
Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer.
Cancer. 1977 Feb;39(2):514-26. doi: 10.1002/1097-0142(197702)39:2<514::aid-cncr2820390220>3.0.co;2-#.
4
Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Cancer. 1975 Jan;35(1):134-43. doi: 10.1002/1097-0142(197501)35:1<134::aid-cncr2820350119>3.0.co;2-g.
5
An evaluation of Corynebacterium parvum during remission maintenance therapy in pediatric patients with acute lymphoblastic leukemia.
Med Pediatr Oncol. 1979;6(2):101-14. doi: 10.1002/mpo.2950060203.
6
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Br J Dis Chest. 1984 Jan;78(1):89-97.
7
Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Cancer Treat Rep. 1978 Jul;62(7):1059-63.
8
Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
J Natl Cancer Inst. 1976 Jul;57(1):225-6. doi: 10.1093/jnci/57.1.225.
9
[Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
Ann Med Interne (Paris). 1976 Jan;127(1):39-42.
10
Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma.
Am J Obstet Gynecol. 1978 Nov 1;132(5):555-60. doi: 10.1016/0002-9378(78)90752-4.
引用本文的文献
1
Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma.
Br J Cancer. 1981 Dec;44(6):856-62. doi: 10.1038/bjc.1981.284.
本文引用的文献
1
Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.
Br Med J. 1970 Feb 28;1(5695):541-4. doi: 10.1136/bmj.1.5695.541.
2
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis.
Cancer. 1971 Oct;28(4):851-5. doi: 10.1002/1097-0142(1971)28:4<851::aid-cncr2820280408>3.0.co;2-e.
3
Clinical immunologic responsiveness in malignant disease. II. In vitro lymphocyte response to phytohemagglutinin and the effect of cytotoxic drugs.
Oncology. 1972;26(4):357-68. doi: 10.1159/000224687.
4
Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study.
J Lab Clin Med. 1974 Apr;83(4):570-7.
5
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
J Exp Med. 1973 Feb 1;137(2):387-410. doi: 10.1084/jem.137.2.387.
6
Lung cancer: perspectives and prospects.
Ann Intern Med. 1970 Dec;73(6):1003-24. doi: 10.7326/0003-4819-73-6-1003.
7
Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
J Natl Cancer Inst. 1975 Nov;55(5):1147-53. doi: 10.1093/jnci/55.5.1147.
8
Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Cancer. 1975 Jan;35(1):134-43. doi: 10.1002/1097-0142(197501)35:1<134::aid-cncr2820350119>3.0.co;2-g.
9
E and EAC rosette-forming cells in healthy donors and cancer patients.
Int Arch Allergy Appl Immunol. 1976;52(1-4):412-6. doi: 10.1159/000231708.
10
The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
Clin Exp Immunol. 1976 Jun;24(3):441-7.
Zotero 插件